Table 4.
Parameters | FMD group (n = 22) | Control group (n = 22) | P ¶ | ||||
---|---|---|---|---|---|---|---|
Baseline | After cycle 8 | P* | Baseline | After cycle 8 | P* | ||
Glucose (mg/dl) | 97 (22) | 97.5 (14) | 0.38 | 97.5 (24.5) | 106 (12.38) | 0.01 | 0.008 |
Insulin (μU/ml) | 14 (12.6) | 12.3 (6.91) | 0.25 | 12.6 (7.93) | 12.85 (11.25) | 0.005 | 0.51 |
IGF-1 (ng/ml) | 181 (30.5) | 172 (27.5) | 0.006 | 181 (30.5) | 181 (22.75) | 0.09 | 0.64 |
hs-CRP (mg/l) | 4.61 (2.16) | 3.49 (2.07) | 0.02 | 5.7 (2.81) | 5.15 (3.21) | 0.11 | 0.01 |
Weight (kg) | 60.5 (6) | 59.5 (7) | 0.77 | 59 (5) | 59.8 (5.73) | 0.85 | 0.88 |
BMI (kg/m2) | 21.2 (2.68) | 21 (2.74) | 0.73 | 21.1 (2.62) | 21.2 (2.59) | 0.81 | 0.79 |
Data presented as Median (IQR). *Within group (comparing between baseline and after cycle 8), Paired t-test was used. ¶Between group (comparing between FMD group and control group), independent t-test was used. IGF1, insulin-like growth factor-1. Hs-CRP, highly sensitive C-reactive protein. BMI, Body mass index.